Advanced Malignant Neoplasm Clinical Trials

5 recruiting

Advanced Malignant Neoplasm Trials at a Glance

7 actively recruiting trials for advanced malignant neoplasm are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Nashville, Los Angeles, and Houston. Lead sponsors running advanced malignant neoplasm studies include Institut du Cancer de Montpellier - Val d'Aurelle, Kura Oncology, Inc., and AtlasMedx, Incorporated.

Browse advanced malignant neoplasm trials by phase

Treatments under study

About Advanced Malignant Neoplasm Clinical Trials

Looking for clinical trials for Advanced Malignant Neoplasm? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Advanced Malignant Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Advanced Malignant Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1Phase 2

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAdvanced Malignant Neoplasm+4 more
Kura Oncology, Inc.263 enrolled56 locationsNCT04067336
Recruiting
Phase 1Phase 2

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Ovarian CancerEndometrial CancerProstate Cancer+5 more
PMV Pharmaceuticals, Inc300 enrolled76 locationsNCT04585750
Recruiting
Phase 2Phase 3

Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma

Rectal CarcinomaLocally Advanced Malignant Neoplasm
Institut du Cancer de Montpellier - Val d'Aurelle1,075 enrolled30 locationsNCT04749108
Recruiting
Phase 1Phase 2

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Breast CancerPancreatic CancerOvarian Cancer+3 more
AtlasMedx, Incorporated122 enrolled4 locationsNCT04503265
Recruiting
Phase 1Phase 2

A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

Advanced Malignant NeoplasmAdvanced or Metastatic Non-small Cell Lung Cancer
SUNHO(China)BioPharmaceutical CO., Ltd.78 enrolled1 locationNCT06581419
Recruiting

Registry Trial to Evaluate the Safety and Efficacy of Hyperthermia in Locally Advanced Cancers

Locally Advanced Malignant Neoplasm
Mahatma Gandhi Institute of Medical Sciences500 enrolled1 locationNCT05099809
Recruiting
Early Phase 1

Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy

Advanced Malignant Neoplasm
Peking University Cancer Hospital & Institute10 enrolled1 locationNCT05985278